Arsenale Bioyards has successfully completed its first $10 million seed financing round. The funding round was led by Planet A and byFounders, with participation from CDP Ventures, Acequia Capital, Plug N Play, and Grey Silo Ventures, along with several family offices. Arsenale aims to reduce costs and production time by up to 90%, making sustainable biobased alternatives more accessible.
The new funding will help Arsenale advance its goal of changing the $200 billion biomanufacturing market. The company focuses on creating sustainable, biobased solutions and innovative approaches in the industry. Arsenale’s platform combines advanced lab and industrial-scale bioreactors with AI-driven software, improving fermentation processes and speeding up production from lab to industrial level.
Arsenale follows a ‘neo-industrial approach’, using nature-inspired principles to make manufacturing more efficient and environmentally friendly. Its key technology, precision fermentation, employs microorganisms, such as yeast and bacteria, to produce proteins and other valuable compounds.
“At Planet A, we saw Arsenale’s potential early on,” said Christoph Gras, Co-Founder of Planet A Ventures. “Their approach changes how biomanufacturing can scale, making it a viable investment.”
“Arsenale is not just imagining the future of the bioeconomy—we are building it now,” said Massimo Portincaso, CEO and Co-Founder of Arsenale Bioyards. “This funding helps us push for real change and highlights our goal of creating a new sustainable industrial model.”
The new financing will support the growth of Arsenale’s infrastructure. It will also accelerate the company’s plans for commercialization in the food and cosmetics industries, reinforcing its role in promoting sustainability and innovation in the industrial sector.
